8,003,386 Tumor necrosis factor receptors 6.alpha. and 6.beta. 7,851,596 Myeloid progenitor inhibitory factor- 1 (MPIF- 1) polypeptides

Transcription

1 PAT. NO. Title 8,163,522 Human TNF receptor 8,105,589 Use of DR3 antibodies in the treatment of inflammatory disease 8,063,182 Human TNF receptor fusion protein 8,003,386 Tumor necrosis factor receptors 6.alpha. and 6.beta. 7,910,321 Methods of determining the level of human tumor necrosis factor receptor- like 2 7,906,119 Antibodies against protective antigen 7,851,596 Myeloid progenitor inhibitory factor- 1 (MPIF- 1) polypeptides 7,824,675 Use of an antibody that binds human tumor necrosis factor receptor- like 2 7,803,615 Death domain containing receptor 5 7,776,560 Human tumor necrosis factor receptor TR9 antibody 7,709,218 Tumor necrosis factor receptors 6.alpha. and 6.beta. 7,708,996 DR3 antibodies 7,601,351 Antibodies against protective antigen 7,534,428 Antibodies to tumor necrosis factor receptors 6.alpha. and 6.beta. 7,511,017 Methods of treatment with TNFR5 7,495,084 Antibodies to T1 receptor- like ligand II 7,476,384 Death domain containing receptor 4 antibody and methods 7,452,538 Death domain containing receptor 4 antibodies and methods 7,446,169 Human tumor necrosis factor receptor- like 2 7,429,646 Antibodies to human tumor necrosis factor receptor- like 2 7,427,492 Polynucleotides encoding human tumor necrosis factor receptor- like2 7,393,943 Polynucleotides encoding a human chemotactic cytokine I 7,374,764 CD33- like protein

2 7,364,865 Antibodies to myeloid progenitor inhibitory factor- 1 (MPIF- 1) 7,357,927 Death domain containing receptors 7,335,489 Polynucleotides encoding a protein kinase C inhibitor protein and methods of using these polynucleotides 7,314,722 Cytostatin II antibodies and methods 7,309,780 Antibodies to natural killer cell activating factor II 7,285,267 Tumor necrosis factor receptors 6.alpha. & 6.beta. 7,232,667 Keratinocyte growth factor- 2 polynucleotides 7,217,788 Human tumor necrosis factor delta polypeptides 7,199,225 Human extracellular matrix- 1 7,186,800 Tumor necrosis factor 6.alpha. and 6.beta. 7,169,566 Metalloproteinases 7,128,906 T1 receptor- like ligand II and uses thereof 7,122,639 Chemokine alpha- 2 antibodies 7,098,316 Human proteins 7,091,322 Human endometrial specific steroid- binding factor I, II, and III 7,078,482 Natural killer cell activating factor II 7,071,312 Epidermal differentiation factor 7,060,272 Death domain containing receptor- 4 agonist antibodies and methods 7,056,516 I- FLICE, a novel inhibitor of tumor necrosis factor receptor- 1 and CD- 95 induced apoptosis 7,049,402 Tumor necrosis factor receptor- 5 7,041,803 Galectin 11 7,041,460 Antibodies to monocyte- colony inhibitory factor (M- CIF) 6,951,735 Death domain containing receptors

3 6,949,358 Human tumor necrosis factor receptor TR9 6,943,020 Death domain containing receptor- 4 antibodies 6,919,433 Antibodies to protein HPMBQ91 6,919,078 Antibodies to human tumor necrosis factor receptor TR9 6,916,786 Keratinocyte growth factor- 2 6,916,629 Tissue factor pathway inhibitor- 3 6,903,072 Keratinocyte growth factor- 2 6,902,910 Death domain containing receptor 4 6,893,870 Pancreas- derived plasminogen activator inhibitor 6,878,812 Metalloproteinases 6,872,568 Death domain containing receptor 5 antibodies 6,869,927 Keratinocyte growth factor- 2 formulations 6,861,226 Human endometrial specific steroid- binding factor I, II and III 6,843,988 Synferon 6,811,773 Human monocyte colony inhibitory factor (M- CIF) polypeptides 6,759,513 Death domain containing receptors 6,746,674 Cytostatin II 6,743,625 Death domain containing receptor 5 6,713,061 Death domain containing receptors 6,693,077 Keratinocyte growth factor- 2 6,680,171 I- FLICE, a novel inhibitor of tumor necrosis factor receptor- 1 and CD- 95 induced apoptosis 6,667,390 Human tumor necrosis factor receptor TR9 6,667,032 T1 receptor- like ligand II polypeptides 6,653,445 Human CCV polypeptides

4 6,653,284 Keratinocyte growth factor- 2 formulations 6,649,738 Pancreas- derived plasminogen activator inhibitor 6,632,425 Chemokine compositions 6,623,938 I- flice, a novel inhibitor of tumor necrosis factor receptor- 1 and CD- 95 induced apoptosis 6,617,132 Human cystatin E polynucleotides 6,610,829 Human extracellular matrix- 1 6,605,699 Galectin- 11 polypeptides 6,605,271 T1 receptor- like ligand II and uses thereof 6,590,088 CD33- like protein 6,586,210 Polynucleotides encoding T1 receptor like ligand II 6,576,745 Human cystatin F antibodies 6,548,262 Methods of measuring tissue factor pathway inhibitor- 3 6,548,063 Synferon 6,541,224 Tumor necrosis factor delta polypeptides 6,509,170 Polynucleotides encoding human tumor necrosis factor delta 6,506,882 Antibodies that bind tumor necrosis factor delta 6,482,922 Mammary transforming protein 6,479,633 Chemokine alpha 2 6,468,768 Galectin 9 and 10SV polynucleotides 6,461,823 Death domain containing receptor- 4 antibodies 6,455,040 Tumor necrosis factor receptor 5 6,448,044 DNA encoding human natural killer cell activating factor II 6,433,147 Death domain containing receptor- 4 6,420,138 Expression control sequences

5 6,413,726 Antibodies that specifically bind Cytostatin III 6,395,538 Method and system for providing real- time, in situ biomanufacturing process monitoring and control in response to IR spectroscopy 6,358,508 Antibodies to human tumor necrosis factor receptor TR9 6,342,363 Death domain containing receptor 4 nucleic acids and methods 6,338,948 Human endometrial specific steroid- binding factor I, II and III 6,329,169 Nucleic acid molecules encoding cytostatin II 6,312,937 Metalloproteinases 6,303,338 Pancreas- derived plasminogen activator inhibitor 6,300,477 Antibodies to human cystatin E 6,294,164 Natural killer cell enhancing factor C 6,287,812 Nucleic acid molecules encoding cytostatin I 6,262,233 Tissue factor pathway inhibitor- 3 6,261,801 Nucleic acids encoding tumor necrosis factor receptor 5 6,255,079 Polynucleotides encoding natural killer cell enhancing factor C 6,238,888 Keratinocyte growth factor- 2 formulations 6,232,291 Cytostatin III 6,194,168 Expression control sequences 6,174,992 Human endometrial specific steroid- binding factor I, II and III 6,153,402 Death domain containing receptors 6,147, lipoxygenase- activating protein II 6,130,061 Human stem cell antigen 2 6,114,145 Synferon, a synthetic interferon 6,090,575 Polynucleotides encoding human G- protein coupled receptor GPR1 6,077,692 Keratinocyte growth factor- 2

6 6,066,724 Human endometrial specific steroid- binding factor I, II and III 6,066,617 Human cystatin F 6,057,434 Mammary transforming protein 6,046,031 Metalloproteinases 6,027,916 Galectin 9 and 10SV Polynucleotides 6,011,012 Human cystatin E 5,998,164 Polynucleotides encoding human G- protein coupled receptor GPRZ 5,985,601 DNA encoding human cystatin E 5,981,220 Epidermal differentiation factor 5,977,309 Cytostatin I 5,968,797 Ubiquitin conjugating enzymes 8 and 9 5,952,197 DNA encoding the chemotactic cytokine III 5,945,321 Ubiquitin conjugating enzymes 7, 8 and 9 5,945,309 Cytostatin III nucleic acids encoding 5,942,417 CD44- like protein and nucleic acids 5,919,658 Human cystatin F 5,912,327 Method of purifying chemokines from inclusion bodies 5,910,431 Polynucleotides encoding chemokine.alpha.- 2 5,874,240 Human 4-1BB receptor splicing variant 5,849,286 Ubiquitin conjugating enzymes 7,8 and 9 5,844,081 Cytostatin I 5,808,029 DNA encoding a human TNF binding protein 5,696, lipoxygenase- activating protein II 5,658,758 Polynucleotides encoding cytostatin I

7 5,650,313 Ubiquitin conjugating enzymes 8 and 9 5,610,279 Human TNF receptor 5,310,663 Affinity peptides 5,284,933 Affinity peptides 5,238,836 Plasmodium falciparum merozoite antigen peptides